FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969874057> ?p ?o ?g. }

• W2969874057 endingPage "6308" @default.
• W2969874057 startingPage "6302" @default.
• W2969874057 abstract "Gastrointestinal stromal tumors (GIST) are resistant to cytotoxic chemotherapy and radiotherapy. Most GIST in children are wild-type for KIT and PDGFRA (WT GIST) and deficient in expression of succinate dehydrogenase (dSDH GIST). We tested the activity of vandetanib, an oral small-molecule inhibitor of VEGFR2, EGFR, and RET, in patients with dSDH GIST.Phase II study of vandetanib (300 mg orally once daily to patients ≥18 years, and 100 mg/m2/dose to patients < 18 years) on a continuous dosing schedule (1 cycle = 28 days) to assess the clinical activity (partial and complete response rate RECIST v1.1) in patients with dSDH GIST. A Simon optimal two-stage design (target response rate 25%, rule out 5%) was used: If ≥1 of 9 patients in stage 1 responded, enrollment would be expanded to 24 patients, and if ≥3 of 24 responded, vandetanib would be considered active.Nine patients (7 female and 2 male; median age, 24 years; range, 11-52) with metastatic disease were enrolled. Three of the initial 5 adult patients developed treatment-modifying toxicities. After a protocol amendment, two adults received vandetanib at 200 mg/dose with improved tolerability. The two children (<18 years old) enrolled did not experience treatment-modifying toxicities. No partial or complete responses were observed (median number of cycles, 4; range, 2-18).Vandetanib at a dose of 300 mg daily was not well tolerated by adults with dSDH GIST. Two of 9 patients had prolonged stable disease, but no partial or complete responses were observed, and vandetanib is thus not considered active in dSDH GIST." @default.
• W2969874057 created "2019-08-29" @default.
• W2969874057 creator A5002479582 @default.
• W2969874057 creator A5004211801 @default.
• W2969874057 creator A5008972260 @default.
• W2969874057 creator A5023012274 @default.
• W2969874057 creator A5024934444 @default.
• W2969874057 creator A5031748968 @default.
• W2969874057 creator A5043356389 @default.
• W2969874057 creator A5044239219 @default.
• W2969874057 creator A5055973779 @default.
• W2969874057 creator A5065281591 @default.
• W2969874057 creator A5066585382 @default.
• W2969874057 creator A5071679104 @default.
• W2969874057 creator A5081018656 @default.
• W2969874057 creator A5088603617 @default.
• W2969874057 creator A5089224710 @default.
• W2969874057 date "2019-11-01" @default.
• W2969874057 modified "2023-10-13" @default.
• W2969874057 title "A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor" @default.
• W2969874057 cites W1562056707 @default.
• W2969874057 cites W1985429138 @default.
• W2969874057 cites W1992412494 @default.
• W2969874057 cites W1995930366 @default.
• W2969874057 cites W2009143024 @default.
• W2969874057 cites W2015015957 @default.
• W2969874057 cites W2019607817 @default.
• W2969874057 cites W2057199368 @default.
• W2969874057 cites W2059864409 @default.
• W2969874057 cites W2061106796 @default.
• W2969874057 cites W2071136688 @default.
• W2969874057 cites W2072841404 @default.
• W2969874057 cites W2095589221 @default.
• W2969874057 cites W2097060135 @default.
• W2969874057 cites W2099067205 @default.
• W2969874057 cites W2112816082 @default.
• W2969874057 cites W2117727059 @default.
• W2969874057 cites W2119501407 @default.
• W2969874057 cites W2123240481 @default.
• W2969874057 cites W2128518955 @default.
• W2969874057 cites W2136749294 @default.
• W2969874057 cites W2139631829 @default.
• W2969874057 cites W2308064764 @default.
• W2969874057 cites W2461823061 @default.
• W2969874057 cites W2547299751 @default.
• W2969874057 cites W2562380622 @default.
• W2969874057 cites W2586519388 @default.
• W2969874057 cites W2767415116 @default.
• W2969874057 cites W2772513551 @default.
• W2969874057 cites W2778917529 @default.
• W2969874057 cites W2782077264 @default.
• W2969874057 cites W2908269836 @default.
• W2969874057 doi "https://doi.org/10.1158/1078-0432.ccr-19-0986" @default.
• W2969874057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6825553" @default.
• W2969874057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31439578" @default.
• W2969874057 hasPublicationYear "2019" @default.
• W2969874057 type Work @default.
• W2969874057 sameAs 2969874057 @default.
• W2969874057 citedByCount "13" @default.
• W2969874057 countsByYear W29698740572019 @default.
• W2969874057 countsByYear W29698740572020 @default.
• W2969874057 countsByYear W29698740572021 @default.
• W2969874057 countsByYear W29698740572022 @default.
• W2969874057 countsByYear W29698740572023 @default.
• W2969874057 crossrefType "journal-article" @default.
• W2969874057 hasAuthorship W2969874057A5002479582 @default.
• W2969874057 hasAuthorship W2969874057A5004211801 @default.
• W2969874057 hasAuthorship W2969874057A5008972260 @default.
• W2969874057 hasAuthorship W2969874057A5023012274 @default.
• W2969874057 hasAuthorship W2969874057A5024934444 @default.
• W2969874057 hasAuthorship W2969874057A5031748968 @default.
• W2969874057 hasAuthorship W2969874057A5043356389 @default.
• W2969874057 hasAuthorship W2969874057A5044239219 @default.
• W2969874057 hasAuthorship W2969874057A5055973779 @default.
• W2969874057 hasAuthorship W2969874057A5065281591 @default.
• W2969874057 hasAuthorship W2969874057A5066585382 @default.
• W2969874057 hasAuthorship W2969874057A5071679104 @default.
• W2969874057 hasAuthorship W2969874057A5081018656 @default.
• W2969874057 hasAuthorship W2969874057A5088603617 @default.
• W2969874057 hasAuthorship W2969874057A5089224710 @default.
• W2969874057 hasBestOaLocation W29698740571 @default.
• W2969874057 hasConcept C121608353 @default.
• W2969874057 hasConcept C126322002 @default.
• W2969874057 hasConcept C143998085 @default.
• W2969874057 hasConcept C16930146 @default.
• W2969874057 hasConcept C170493617 @default.
• W2969874057 hasConcept C197934379 @default.
• W2969874057 hasConcept C2775922572 @default.
• W2969874057 hasConcept C2776694085 @default.
• W2969874057 hasConcept C2777288759 @default.
• W2969874057 hasConcept C2778375690 @default.
• W2969874057 hasConcept C2778820342 @default.
• W2969874057 hasConcept C2780333294 @default.
• W2969874057 hasConcept C31760486 @default.
• W2969874057 hasConcept C42362537 @default.
• W2969874057 hasConcept C71924100 @default.
• W2969874057 hasConcept C90924648 @default.
• W2969874057 hasConceptScore W2969874057C121608353 @default.

• next